Vol 11, Núm 2

Enfermedad estreptocócica, más allá de la garganta en la edad pediátrica. Reporte de casos.

Kassisse J, Kassise E, Bataglini I. 

 

Texto completo [PDF]

Resumen (ES)

El espectro de las manifestaciones clínicas de la enfermedad por Streptococcus pyogenes son múltiples y variadas, la enfermedad invasiva se define como la resultante del aislamiento de esta bacteria de sitios estériles del organismo. La falta de reconocimiento oportuno incrementa el riesgo de morbilidad, de mortalidad así como de las potenciales secuelas incapacitantes. El objetivo de esta investigación es el de presentar dos casos de enfermedad severa secundaria a Streptococcus pyogenes resaltando la importancia del espectro de la enfermedad más allá de los límites de la orofaringe, como lo fueron la forma severa de la infección de la piel con manifestaciones tóxicas, la fascitis necrotizante y el segundo la invasión pulmonar en el curso de la varicela. El estudio nos permitió reafirmar la susceptibilidad del Streptococcus pyogenes a la penicilina así como el reconocimiento oportuno es capaz de modificar de forma favorable el curso de la enfermedad.

Palabras clave: Aislamiento, empiema, fascitis necrotizante, varicela.

Resumen (EN)

The spectrum of clinical manifestations of disease by Streptococcus pyogenes are many and varied, invasive disease is defined as the resulting isolation of the bacteria from sterile sites in the body. The lack of timely recognition increases the risk of morbidity, mortality and potential disabling consequences. The objective of this research is to present two cases of severe disease secondary to Streptococcus pyogenes highlighting the importance of disease spectrum beyond boundaries of the oropharynx, as were the severe form of skin infection with toxic manifestations, necrotizing fasciitis and second pulmonary invasion during chickenpox. The study allowed us to reaffirm the susceptibility of Streptococcus pyogenes to penicillin and timely recognition is able to modify favorably the course of the disease.

Keywords: Isolation, empyema, necrotizing fasciitis, chickenpox.

Licencia de Creative Commons

Referencias

  1. Carapetis J, Steer A, Mulholland E, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis.2005;5(11): 685–694.
  2. Martin J, Green M & M. Group A Streptococcus. Semin Pediatr Infect Dis. 2006;17(3):140-148.
  3. López A, Peraza S, Gabrielli G, Burdeinick I, Gabrielli I, Urdaneta C. Zigomicosis cutánea en un paciente de 10 años. Primer caso pediátrico en Venezuela. Revisión de la literatura. Arch Venez Pueric Pediatr. 2007;70(1):22-27.
  4. Canelón D, Fargier A, León G, Silva M, Uzcátegui E. Fascitis necrotizante de punto de partida abdominal: a propósito de un caso. Avances en Biomedicina 2012;1(1):42-45
  5. Curiel M, Morillo, E, Centritto C, Guigñan O, Arias F. Fasceitis necrotizante y púrpura fulminante por estreptococo del grupo A secundario a varicela en un caso pediátrico Arch Venez Pueric Pediatr. 2003;66(4):27-32
  6. Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am. 2003;85(8):1454-1460.
  7. Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007;44(5):705-710.
  8. Lamagni T, Darenberg J, Luca-Harari B, Siljander T, Efstratiou, A, HenriquesNormark B, et al. Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol. 2008;46(7):2359-2367.
  9. Wahl RU, Lutticken R, Stanzel S, van der Linden M, Reinert RR. Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996–2002: results from a voluntary laboratory surveillance system. Clin Microbiol Infec. 2007;13:1173–1178
  10. Patel RA, Binns HJ, Shulman ST. Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era. J Pediatr. 2004;144(1):68–74.
  11. Debra M, Margie A. Group A Streptococcal Infections Pediatrics in Review. 2011;32(10):423-430.
  12. Chan T, Yaghoubian A, Rosing D, Kaji A, de Virgilio C. Low sensitivity of physical examination findings in necrotizing soft tissue infection is improved with laboratory values: a prospective study. AmJ Surg. 2008;196(6):926-930
  13. Gunnar T, Axel W, Johan Tham. Ten years of treating necrotizing fascitis. Infectious Diseases. 2015;47(5):319–325
  14. Andreasen TJ, Green SD, Childers BJ. Massive infectious soft-tissue injury: diagnosis and management of necrotizing fasciitis and purpura fulminans. Plast Reconstr Surg. 2009;208(2):279-288.
  15. Lancerotto L, Tocco I, Salmaso R, Vindigni V, Bassetto F. Necrotizing fasciitis: classification, diagnosis, and management. J Trauma Acute Care Surg. 2012;72(3):560-566.
  16. Sikora CA, Spielman J, Macdonald K, Tyrrell GJ, Embil JM. Necrotizing fasciitis resulting from human bites: a report of two cases of disease caused by group A Streptococcus. Can J Infect Dis Med Microbiol. 2005;16:221–224.
  17. Sarani B, Strong M, Pascual J, Schwab CW. Necrotizing fasciitis: current concepts and review of the literature
  18. Stevens D, Bisno A, Chambers H, Dellinger E Goldstein, E, Gorbach S, et al. Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):147–159
  19. Carapetis J, Jacoby P, Carville K, Joel Ang Curtis, N, Andrews R. Effectiveness of Clindamycin and Intravenous Immunoglobulin, and Risk of Disease in Contacts, in Invasive Group A Streptococcal Infections. Clin Infect Dis. 2014;59(3):358–365
  20. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352:1445–1453.
  21. Patcharin K, Wilaiwan C, Kijja J, Jayanton P, Apichat T. Necrotizing fasciitis: epidemiology and clinical predictors for amputation. Int J Gen Med 2015;14(8):195–202.
  22. Lukkarinen H, Marttila H, Perttilä J, Virkki R, Ruuskanen O. Group A streptococcal pneumonia. Duodecim. 2012;128(8):825-829.
  23. Requena L, Requena C. Histopathology of the more common viral skin infections. Actas Dermosifiliogr. 2010;101(3):201–216.
  24. Matthias I, Mark L, Ralf R, Klaus R. Invasive group A streptococcal isease and association with varicella in Germany, 1996-2009. Immunol Med Microbiol. 2011;62(1):101–109.
  25. Henriet S, Kaguelidou F, Bidet P, Lorrot M, De Lauzanne A, Dauger S, et al. Invasive group A streptococcal infection in children: clinical manifestations and molecular characterization in a French pediatric tertiary care center. Eur J Clin Microbiol Infect Dis. 2010;29(3):341-346.
  26. Tart AH, Walker MJ, Musser JM. New understanding of the group A Streptococcus pathogenesis cycle. Trends Microbiol. 2007;15(7):318-325.
  27. Sumby P, Whitney AR, Graviss EA, DeLeo FR, Musser JM. Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype anddisease specificity. PLoS Pathog. 2006;2:41-49
  28. Al-kaabi N, Solh Z, Pacheco S, Murray l, Gaboury I. A comparison of group A Streptococcus versus Streptococcus pneumoniae pneumonia. Pediatr Infect Dis J. 2006;25(11):1008-1012